Glucagon therapy as a possible cause of erythema necrolyticum migrans in two neonates with persistent hyperinsulinaemic hypoglycaemia

European Journal of Pediatrics

Volumn 161, Issue 11, 2002, Pages 600-603

  Wald, Martin ^a   Lawrenz, Karin ^b   Luckner, Doris ^a   Seimann, Richard ^c   Mohnike, Klaus ^d   Schober, Edith ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c KEPLER UNIVERSITY HOSPITAL   (Austria)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Erythema necrolyticum migrans; Glucagon; Glucagonoma; Persistent hyperinsulinaemic hypoglycaemia of infancy

Indexed keywords

CHLOROTHIAZIDE; DIAZOXIDE; GLUCAGON; HYDROCHLOROTHIAZIDE; NIFEDIPINE; OCTREOTIDE; STEROID;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ERYTHEMA NECROLYTICUM MIGRAN; FEMALE; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; LABORATORY TEST; NEWBORN; NEWBORN DISEASE; PANCREAS RESECTION; PRIORITY JOURNAL; SKIN DISEASE; TREATMENT OUTCOME;

DISEASES IN TWINS; ERYTHEMA; FEMALE; GLUCAGON; HUMANS; HYPERINSULINISM; HYPOGLYCEMIA; INFANT, NEWBORN;

EID: 0036460561     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-002-1022-9     Document Type: Article

References (28)

1. Alkemade JAC, van Tongeren JHM, van Haelst UJGM, Smals A, Steijlen PM, van de Kerkhof PCM (1999) Delayed diagnosis of glucagonoma syndrome. Clin Exp Dermatol 24: 455-457
2. Aynsley-Green A, Hussain K, Hall J, Saudubray JM, Nihoul-Fekete C, De Lonlay-Debeney P, Brunelle F, Otonkoski T, Thorton P, Lindley KJ (2000) Practical management of hy-perinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed 82: F98-F107
3. Becker WS, Khan D, Rothman S (1942) Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syphilol 45: 1069-1080
4. Blackford S, Wright S, Roberts DL (1991) Necrolytic migratory erythema without glucagonoma: The role of dietary essential fatty acids. Br J Dermatol 125: 460-462
5. Braun-Falco O, Plewig G, Wol3 HH (1995) Dermatologie und Venerologie, 4 Edn. Springer, Berlin Heidelberg New York, p 530
6. Bruining GJ (1990) Recent advances in hyperinsulism and the pathogenesis of diabetes mellitus. Curr Opin Pediatr 2: 758-765
7. Ching JLC, Anderson JV, Williams SJ (1986) Remission of symptoms during long-term treatment of metastatic pancreatic endocrine tumors with long-acting somatostatin-analogue. BMJ 292: 981-982
8. De Lonlay-Debene P, Poggi-Travert F, Fournet JC, Sempoux C, Vici CD, Brunelle F, Tonati G, Rahier J, Junien C, Nikoul-Fekete C, Robert JJ, Saudubray JM (1999) Clinical features of 52 neonates with hyperinsulinism N Engl J Med 340: 1169-1175
9. El Rassi Z, Partensky C, Vallette PJ, Berger F, Chyvialle JA (1998) Necrolytic migratory erythema, first symptom of a malignant glucagonoma: Treatment by long-acting somatosta-tin and surgical resection. Report of three cases. Eur J Surg Oncol 24: 562-567
10. Hashizume T, Kiryn H, Noda K, Kano T, Nakano R (1988) Glucagonoma syndrome. J Am Acad Dermatol 19: 377-383
11. Joseph K, Stapp J,Reinecke J, Skamel HJ, Hoffken H, Neuhaus C, Lenze H, Trautman ME, Arnold R (1993) Receptor scintigraphy with 111 In-pentetreotide for endocrine gastroenteropancreatic tumors. Horm Metab Res Suppl 27: 28-35
12. Kasper CS, McMurry K (1991) Necrolytic migratory erythema without glucagonoma versus canine superficial necrolytic dermatitis: Is hepatic impairment a clue to pathogenesis? J Am Acad Dermatol 25: 534-541
13. Konstantinow A, Balda BR, Starz H (1998) Erythema necro-lyticum migrans nach Rectumadenokarzinom. Hautarzt 49: 591-595
14. Lubetzki J, Guillausseau PJ, Binet O, Hautefeuille P, Galiant A, Mindler O, Aron-Brunetiere R, Timsit J, Warnet A (1981) Pseudoglucagonoma responsive to somatostatin. Lancet 11: 316-317
15. Mullans EA, Cohen PR (1998) Iatrogenic necrolytic migratory erythema: A case report and review of nonglucagonoma-associated necrolytic migratory erythema. J Am Acad Dermatol 38: 866-873
16. Norton JA, Kahn CR, Schiesinger R, Gorschboth C, Brennan MF (1979) Amino acid deficiency and the skin rash associated with glucagonoma. Ann Intern Med 91: 213-215
17. Ossowski B, Baum C (1995) Das pseudoglucagonom-syndrom. Hautarzt 46: 173-176
18. Rappersberger K, Wolff-Schreiner E, Konrad K, Wolff K (1987) Das glukagonom-syndrom. Hautarzt 38: 589-598
19. Recant L, Perrino PV, Bhathena SJ, Oanforth ON, Lavine RL (1976) Plasma immunoreactive glucagon fractions in four cases of glucagonoma: Increased "large glucagon-immunoreactivity". Diabetologia 12: 319-326
20. Shepherd RM, Cosgrove KE, O'Brien RE, Barnes PD, Am-mala C, Dunne MJ (2000) Hyperinsulinism in infancy: Towards an understanding of unregulated insulin release. Arch Dis Child Fetal Neonatal Ed 82: F87-F97
21. Stanley CA (1997) Hyperinsulinism in infants and children. Pediatr Clin North Am 44: 363-374
22. Tanner M, Brasch J, Christophers E (1994) Erythema necroticans migrans ohne glucagonom. Hautarzt 45: 480-483
23. Thivolet J, Perrot H, Pellerat J (1974) Érythème cutané migrateur avec nécrose épidermique superficielle au cours d'une pancréatite chronique. Ann Dermatol Syphiligr 101: 415-417
24. Thomas CG Jr, Underwood LE, Carney CN, Dolcourt JL, Whitt JJ (1977) Neonatal and infantile hypoglycemia due to insulin excess: New aspects of diagnosis and surgical management. Ann Surg 185: 505-517
25. Thorisdottir K, Camisa C, Tomecki KJ, Bergfeld WF (1994) Necrolytic migratory erythema: A report of three cases. J Am Acad Dermatol 30: 324-329
26. Valverde I, Villanueva ML, Lozano I, Marco J (1974) Presence of glucagon immunoreactivity in the globulin fraction of human plasma ("big plasma glucagon"). J Clin Endocrinol Metab 39: 1090-1098
27. Walker NP (1982) Atypical necrolytic migratory erythema in association with a jejunal adenocarcinoma. J R Soc Med 75: 134-135
28. Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV (1996) The glucagonoma syndrome. Clinical and pathological features in 21 patients. Medicine (Baltimore) 75: 53-63